Aurora Private Wealth’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,656
Closed -$3.33M 222
2021
Q3
$3.33M Buy
8,656
+188
+2% +$69.3K 1.35% 14
2021
Q2
$1.99M Buy
8,468
+137
+2% +$24.5K 0.8% 24
2021
Q1
$1.09M Buy
8,331
+1,132
+16% +$164K 0.45% 43
2020
Q4
$752K Buy
7,199
+3,644
+103% +$369K 0.32% 70
2020
Q3
$252K Buy
+3,555
New +$248K 0.11% 159

Other funds holding MRNA

Aurora Private Wealth's MRNA Position: Q4 2021 in Review

Aurora Private Wealth sold out of Moderna (MRNA) in Q4 2021, closing a stake of 8,656 shares — an estimated $3.33M sold.

Aurora Private Wealth first reported a position in MRNA in Q3 2020 and held it in 5 quarters. The position peaked at $3.33M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Aurora Private Wealth reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Aurora Private Wealth sold 8,656 Moderna shares in Q4 2021, an estimated $3.33M.
  • Aurora Private Wealth first reported a position in Moderna in Q3 2020 and held it in 5 quarters.
  • Aurora Private Wealth's Moderna position peaked at $3.33M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Aurora Private Wealth's 13F filing for Q4 2021, filed 2 Feb 2022.